FDA Approves Avaclyr (acyclovir ophthalmic ointment) for the Treatment of Herpetic Keratitis
NEW YORK–(BUSINESS WIRE) April 01, 2019–The US Food and Drug Administration (FDA) has approved Fera Pharmaceuticals' New Drug Application (NDA) for Avaclyr (acyclovir ophthalmic ointment) 3% for the treatment of herpetic keratitis....
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news
More News: Acyclovir | Drugs & Pharmacology | Food and Drug Administration (FDA) | New Drug Applications | Opthalmology | Zovirax